These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32870050)

  • 21. The usefulness of interferon-gamma release assay for diagnosis of tuberculosis-related uveitis in Korea.
    Ahn SJ; Kim KE; Woo SJ; Park KH
    Korean J Ophthalmol; 2014 Jun; 28(3):226-33. PubMed ID: 24882956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic categorization according to the First International Workshop on Ocular Sarcoidosis (FIWOS) criteria in a series of 11 patients.
    Meneses CF; Egües CA; Uriarte M; Errazquin N; Valero Jaimes A; Maíz O; Belzunegui J; Blanco A
    Reumatol Clin; 2017; 13(1):25-29. PubMed ID: 26948714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcoid Uveitis: An Intriguing Challenger.
    Allegri P; Olivari S; Rissotto F; Rissotto R
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caveats about QuantiFERON-TB gold in-tube testing for uveitis.
    Pepple KL; Van Gelder R; Forooghian F
    Am J Ophthalmol; 2014 Apr; 157(4):752-3. PubMed ID: 24630206
    [No Abstract]   [Full Text] [Related]  

  • 25. Looking for Ocular Tuberculosis: Prevalence and Clinical Manifestations of Patients with Uveitis and Positive QuantiFERON
    Pathanapitoon K; Kunavisarut P; Sirirungsi W; Rothova A
    Ocul Immunol Inflamm; 2018; 26(6):819-826. PubMed ID: 27849401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity.
    Patel SS; Saraiya NV; Tessler HH; Goldstein DA
    JAMA Ophthalmol; 2013 Jun; 131(6):752-8. PubMed ID: 23579549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early treatment of tuberculous uveitis improves visual outcome: a 10-year cohort study.
    Anibarro L; Cortés E; Chouza A; Parafita-Fernández A; García JC; Pena A; Fernández-Cid C; González-Fernández Á
    Infection; 2018 Aug; 46(4):549-554. PubMed ID: 29869018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcoidosis and uveitis.
    Jamilloux Y; Kodjikian L; Broussolle C; Sève P
    Autoimmun Rev; 2014 Aug; 13(8):840-9. PubMed ID: 24704868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low utility of ocular screening in sarcoidosis in Finland.
    Joukainen E; Antonen J; Leinonen S
    Acta Ophthalmol; 2024 Jun; 102(4):435-440. PubMed ID: 37665138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India.
    Sudharshan S; Ganesh SK; Balu G; Mahalakshmi B; Therese LK; Madhavan HN; Biswas J
    Int Ophthalmol; 2012 Jun; 32(3):217-23. PubMed ID: 22527447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ocular and neuro-ophthalmic manifestations of sarcoidosis: retrospective study of 30 cases].
    Bezo C; Majzoub S; Nochez Y; Leruez S; Charlin JF; Milea D; Pisella PJ
    J Fr Ophtalmol; 2013 Jun; 36(6):473-80. PubMed ID: 23545336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of routine tuberculosis screening in county hospital patients with uveitis.
    Hong BK; Khanamiri HN; Bababeygy SR; Rao NA
    Br J Ophthalmol; 2014 Aug; 98(8):1091-5. PubMed ID: 24489378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular and systemic features of sarcoidosis and correlation with the International Workshop for Ocular Sarcoidosis diagnostic criteria.
    Agrawal R; Gonzalez-Lopez JJ; Meier F; Gupta B; Pavesio CE
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):237-45. PubMed ID: 26422569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis.
    Caspers L; Makhoul D; Ebraert H; Michel O; Willermain F
    Am J Ophthalmol; 2014 Sep; 158(3):646-7. PubMed ID: 25132253
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognosis of Ocular Tuberculosis Following Long-Term Antitubercular Therapy.
    Jiang T; Zhang X; Zhou M; Jiang R; Chang Q
    J Ocul Pharmacol Ther; 2021 May; 37(4):241-247. PubMed ID: 33524301
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of Positive QuantiFERON-TB Gold In-Tube Test in Uveitis and its Clinical Implications in a Country Nonendemic for Tuberculosis.
    Groen-Hakan F; van Laar JAM; Bakker M; van Hagen PM; Hardjosantoso H; Rothova A
    Am J Ophthalmol; 2020 Mar; 211():151-158. PubMed ID: 31734135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presumed Tuberculous uveitis: clinical features and management.
    Gargouri S; Kaibi I; Zone I; Khairallah M; Koubaa M; Ben Jemaa M; Feki J
    Tunis Med; 2019 Jan; 97(1):106-112. PubMed ID: 31535701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presumed tuberculosis-associated uveitis: rising incidence and widening criteria for diagnosis in a non-endemic area.
    Krassas N; Wells J; Bell C; Woodhead M; Jones N
    Eye (Lond); 2018 Jan; 32(1):87-92. PubMed ID: 28776591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey.
    Sungur G; Hazirolan D; Bilgin G
    Ocul Immunol Inflamm; 2013 Dec; 21(6):455-61. PubMed ID: 23909887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Features of Ocular Sarcoidosis in Patients with Biopsy-proven Pulmonary Sarcoidosis in Serbia.
    Radosavljević A; Jakšić V; Pezo L; Kovačević-Pavićević D; Ilić A; Mihailović Vučinić V
    Ocul Immunol Inflamm; 2017 Dec; 25(6):785-789. PubMed ID: 27191355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.